Literature DB >> 22882459

Overview of pharmacoeconomic modelling methods.

Zanfina Ademi1, Hansoo Kim, Ella Zomer, Christopher M Reid, Bruce Hollingsworth, Danny Liew.   

Abstract

In the current climate of burgeoning health care costs, pharmacoeconomics is becoming increasingly important, but knowledge about pharmacoeconomic methods is limited among most clinicians. This review provides an introduction to, and overview of, common methods used in pharmacoeconomic modelling: decision analysis, Markov modelling, discounting and uncertainty analyses via Monte Carlo simulation. It will conclude with a suggested approach to reading and appraising published pharmacoeconomic analyses.
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Mesh:

Year:  2013        PMID: 22882459      PMCID: PMC3612711          DOI: 10.1111/j.1365-2125.2012.04421.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

Review 1.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 2.  An introduction to Markov modelling for economic evaluation.

Authors:  A Briggs; M Sculpher
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

3.  Epidemiological modelling (including economic modelling) and its role in preventive drug therapy.

Authors:  Danny Liew; John J McNeil; Anna Peeters; Stephen S Lim; Theo Vos
Journal:  Med J Aust       Date:  2002-10-07       Impact factor: 7.738

4.  Discounting health outcomes in economic evaluation: the ongoing debate.

Authors:  Johan L Severens; Richard J Milne
Journal:  Value Health       Date:  2004 Jul-Aug       Impact factor: 5.725

Review 5.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  L B Russell; M R Gold; J E Siegel; N Daniels; M C Weinstein
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

Review 6.  Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs.

Authors:  B R Flay
Journal:  Prev Med       Date:  1986-09       Impact factor: 4.018

7.  Markov models in medical decision making: a practical guide.

Authors:  F A Sonnenberg; J R Beck
Journal:  Med Decis Making       Date:  1993 Oct-Dec       Impact factor: 2.583

Review 8.  Decision analysis in patient care.

Authors:  G Elwyn; A Edwards; M Eccles; D Rovner
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

9.  Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting.

Authors:  Stavros Petrou; Alastair Gray
Journal:  BMJ       Date:  2011-04-11

10.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.

Authors:  Alan A Montgomery; Tom Fahey; Yoav Ben-Shlomo; James Harding
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

View more
  13 in total

1.  Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

Authors:  Rochelle P Walensky; Eric L Ross; Nagalingeswaran Kumarasamy; Robin Wood; Farzad Noubary; A David Paltiel; Yoriko M Nakamura; Sheela V Godbole; Ravindre Panchia; Ian Sanne; Milton C Weinstein; Elena Losina; Kenneth H Mayer; Ying Q Chen; Lei Wang; Marybeth McCauley; Theresa Gamble; George R Seage; Myron S Cohen; Kenneth A Freedberg
Journal:  N Engl J Med       Date:  2013-10-31       Impact factor: 91.245

2.  Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis.

Authors:  Irma Convertino; Stefano Salvadori; Alessandro Pecori; Maria Teresa Galiulo; Sara Ferraro; Maria Parrilli; Tiberio Corona; Giuseppe Turchetti; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

3.  Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.

Authors:  Ken LaPensee; Thomas Lodise
Journal:  Am Health Drug Benefits       Date:  2018-12

4.  A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.

Authors:  Elahe Khorasani; Majid Davari; Abbas Kebriaeezadeh; Farshad Fatemi; Ali Akbari Sari; Vida Varahrami
Journal:  Eur J Health Econ       Date:  2022-03-02

5.  Pharmaceutical Supply Chain Practices and Its Associated Factors in Public Health Facilities, West Gojjam Zone, Ethiopia: Cross-Sectional Study.

Authors:  Bereket Bahiru Tefera; Gizachew Tilahun Anbessa
Journal:  Hosp Pharm       Date:  2022-02-28

6.  Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.

Authors:  A Kowada
Journal:  Epidemiol Infect       Date:  2018-07-30       Impact factor: 4.434

Review 7.  Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials.

Authors:  Francesca Tartari; Alessandro Conti; Roy Cerqueti
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

8.  Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus.

Authors:  Ana Carolina Oliveira Gonçalves; Maurílio de Souza Cazarim; Cristina Sanches; Leonardo Regis Leira Pereira; Ana Márcia Tomé Camargos; Jéssica Azevedo Aquino; Andre Oliveira Baldoni
Journal:  BMJ Open Diabetes Res Care       Date:  2019-07-16

9.  The impact of diabetes on the productivity and economy of Bangladesh.

Authors:  Afsana Afroz; Thomas R Hird; Ella Zomer; Alice Owen; Lei Chen; Zanfina Ademi; Danny Liew; Dianna J Magliano; Baki Billah
Journal:  BMJ Glob Health       Date:  2020-06

10.  Efficacy and safety of thread embedding acupuncture combined with acupuncture for chronic low back pain: A randomized, controlled, assessor-blinded, multicenter clinical trial.

Authors:  Won-Suk Sung; Yejin Hong; Sae-Rom Jeon; Jimin Yoon; Eun Kyoung Chung; Hyeong Geun Jo; Tae-Hun Kim; Seungwon Shin; Hyun-Jong Lee; Eun-Jung Kim; Byung-Kwan Seo; Jieun Choi; Dongwoo Nam
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.